Early decrease of interferon-gamma+ and interleukin-2+ T cells during combination treatment with interferon-alpha and ribavirin in patients with chronic hepatitis C. [electronic resource]
Producer: 20010201Description: 3670-3 p. digitalISSN:- 0002-9270
- Antiviral Agents -- therapeutic use
- CD4-Positive T-Lymphocytes -- immunology
- CD8-Positive T-Lymphocytes -- immunology
- Case-Control Studies
- Drug Therapy, Combination
- Female
- Hepatitis C, Chronic -- blood
- Humans
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Interferon-gamma -- immunology
- Interleukin-2 -- immunology
- Male
- Middle Aged
- Recombinant Proteins
- Ribavirin -- therapeutic use
- T-Lymphocyte Subsets -- immunology
- Time Factors
No physical items for this record
Publication Type: Letter; Research Support, Non-U.S. Gov't; Comment
There are no comments on this title.
Log in to your account to post a comment.